Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Recruiting 2Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 55Leukemia 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma 21Lymphoma, Large B-Cell, Diffuse 18Lymphoma, Non-Hodgkin 13Leukemia, Monocytic, Acute 10Lymphoma, Mantle-Cell 9Leukemia, Myelomonocytic, Acute 9Leukemia, Megakaryoblastic, Acute 8Leukemia, Erythroblastic, Acute 8Recurrence 7Myelodysplastic Syndromes 7Burkitt Lymphoma 7Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Follicular 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Congenital Abnormalities 5Leukemia, Myeloid, Chronic-Phase 4Hodgkin Disease 4Multiple Myeloma 3Leukemia, Promyelocytic, Acute 3Leukemia, Eosinophilic, Acute 3Leukemia, Basophilic, Acute 3Anemia, Refractory, with Excess of Blasts 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, T-Cell 2Leukemia, Myelomonocytic, Chronic 2

Interventions

Immunotherapy, Adoptive 2flumatinib 1fludarabine 1Thiotepa 1Sensitivity and Specificity 1Imatinib Mesylate 1Idarubicin 1Diagnosis 1Deferasirox 1Decitabine 1Daunorubicin 1Cytarabine 1Cladribine 1Busulfan 1Blood Specimen Collection 1Azacitidine 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myeloid × Cytarabine × Clear all
NCT03417427 2020-04-27

A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

Nanfang Hospital, Southern Medical University

Phase 2 Unknown
100 enrolled
Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡